October 2014

Recent drug approvals and continuing breakthroughs in research are creating additional treatment options for patients with hepatitis C.

Treatment for hepatitis C should be offered to the sickest patients first, according to updated guidelines from the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases.

In 2 recent studies, statins and aspirin have been associated with lower rates of progression of liver fibrosis in patients with hepatitis C.

Screening of newborn children for hepatitis C and new, more effective hepatitis C treatments may virtually eliminate the disease in the United States by 2036, according to some liver disease experts.